Replies to post #254808 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Cost is lower, possibly easier to get a greater variety of sites due to simpler protocol. Possibly easier to recruit for...who turns down a swish and spit to have a chance at reduced OM?

[Minnesinger]

It's been my belief that the series...

of 'checklist' PRs we've received over the last few weeks have been more for their benefit - opposite stakeholders - not ours.

When negotiating the terms, there are several dozen possibilities based on share price. It is actually a little more complicated at these levels due to “appearance” to opposite stakeholders.

[seek the light]

DaubersUp .....Yes in my opinion, the phase 3 can be done much more quickly than the standard phase 3 for other drugs. Because the results are observable to the eye and therefore much less expensive and the 16 week total time frame from start to finish for treatment for each patient is much less time to completion than on most other drugs.

My conclusion is that with the right partner the whole process could be completed from first enrollment to FDA approval in about 1 year. Of course i am assuming very good results for the patients.

And if i am close to correct in the above that also makes the value much higher RIGHT NOW than the other drugs.

[loanranger]

"I understand it’s same time frames with patients, but due to oral mouthwash type drug, are there any positives?"

A cost savings from the elimination of infusion equipment (tubing, bags, etc that needs to be tossed) and technician costs (insertion and monitoring), but I wouldn't think that there would be much of an overall time savings.